BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36241376)

  • 1. Impact of implementing the aseptic compounding management system, Medcura, on internal error rates within an oncology pharmacy aseptic unit: a mixed methods evaluation.
    Smith E; Fox A; Willmers G; Wright D; Stuart B
    Eur J Hosp Pharm; 2024 Apr; 31(3):220-226. PubMed ID: 36241376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Errors associated with the preparation of aseptic products in UK hospital pharmacies: lessons from the national aseptic error reporting scheme.
    Bateman R; Donyai P
    Qual Saf Health Care; 2010 Oct; 19(5):e29. PubMed ID: 20427304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies implementation to reduce medicine preparation error rate in neonatal intensive care units.
    Campino A; Santesteban E; Pascual P; Sordo B; Arranz C; Unceta M; Lopez-de-Heredia I
    Eur J Pediatr; 2016 Jun; 175(6):755-65. PubMed ID: 26670025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of real-time data obtained from gravimetric preparation of antineoplastic agents shows medication errors with possible critical therapeutic impact: Results of a large-scale, multicentre, multinational, retrospective study.
    Terkola R; Czejka M; Bérubé J
    J Clin Pharm Ther; 2017 Aug; 42(4):446-453. PubMed ID: 28429389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Validation of aseptic technique of parenteral nutrition compounding in a pharmacy service according to USP Chapter 797].
    Romero Jiménez RM; Pernía López MS; Sánchez Fresneda MN; Sanjurjo Sáez M
    Nutr Hosp; 2013; 28(5):1494-7. PubMed ID: 24160206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous Chemotherapy Compounding Errors in a Follow-Up Pan-Canadian Observational Study.
    Gilbert RE; Kozak MC; Dobish RB; Bourrier VC; Koke PM; Kukreti V; Logan HA; Easty AC; Trbovich PL
    J Oncol Pract; 2018 May; 14(5):e295-e303. PubMed ID: 29676947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compounding & dispensing errors before and after implementing barcode technology in a nuclear pharmacy.
    Galbraith W; Shadid J
    Int J Pharm Compd; 2012; 16(3):253-6. PubMed ID: 23050303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiological validation of a robot for the sterile compounding of injectable non-hazardous medications in a hospital environment.
    Sabatini L; Paolucci D; Marinelli F; Pianetti A; Sbaffo M; Bufarini C; Sisti M
    Eur J Hosp Pharm; 2020 Mar; 27(e1):e63-e68. PubMed ID: 32296508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of an i.v.-compounding robot in a hospital-based cancer center pharmacy.
    Yaniv AW; Knoer SJ
    Am J Health Syst Pharm; 2013 Nov; 70(22):2030-7. PubMed ID: 24173011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robotic dispensing improves patient safety, inventory management, and staff satisfaction in an outpatient hospital pharmacy.
    Rodriguez-Gonzalez CG; Herranz-Alonso A; Escudero-Vilaplana V; Ais-Larisgoitia MA; Iglesias-Peinado I; Sanjurjo-Saez M
    J Eval Clin Pract; 2019 Feb; 25(1):28-35. PubMed ID: 30136339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for i.v. compounding errors when using an automated workflow management system.
    Deng Y; Lin AC; Hingl J; Huang G; Altaye M; Maynard H; Mayhaus D; Penm J
    Am J Health Syst Pharm; 2016 Jun; 73(12):887-93. PubMed ID: 27261239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Observational study of accuracy in compounding i.v. admixtures at five hospitals.
    Flynn EA; Pearson RE; Barker KN
    Am J Health Syst Pharm; 1997 Apr; 54(8):904-12. PubMed ID: 9114922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication dispensing errors and potential adverse drug events before and after implementing bar code technology in the pharmacy.
    Poon EG; Cina JL; Churchill W; Patel N; Featherstone E; Rothschild JM; Keohane CA; Whittemore AD; Bates DW; Gandhi TK
    Ann Intern Med; 2006 Sep; 145(6):426-34. PubMed ID: 16983130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of two work practice changes on the microbial contamination rates of pharmacy-compounded sterile preparations.
    Trissel LA; Gentempo JA; Saenz LM; Woodard MY; Angeles CH
    Am J Health Syst Pharm; 2007 Apr; 64(8):837-41. PubMed ID: 17420200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of gravimetric-based technology-assisted workflow for nonhazardous sterile product preparation.
    Bucci TG; Hedrick TL; Roberts PA; Lin K; South MD; Willoughby IR; Eckel SF; Hess ET; Eberwein S; Amerine LB
    Am J Health Syst Pharm; 2019 Jul; 76(14):1071-1077. PubMed ID: 31361879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risks and medication errors analysis to evaluate the impact of a chemotherapy compounding workflow management system on cancer patients' safety.
    Marzal-Alfaro M; Rodriguez-Gonzalez CG; Escudero-Vilaplana V; Revuelta-Herrero JL; González-Haba E; Ibáñez-Garcia S; Iglesias-Peinado I; Herranz-Alonso A; Sanjurjo Saez M
    Health Informatics J; 2020 Sep; 26(3):1995-2010. PubMed ID: 31912756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applying Lean Sigma solutions to mistake-proof the chemotherapy preparation process.
    Aboumatar HJ; Winner L; Davis R; Peterson A; Hill R; Frank S; Almuete V; Leung TV; Trovitch P; Farmer D
    Jt Comm J Qual Patient Saf; 2010 Feb; 36(2):79-86. PubMed ID: 20180440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A virtual centralized cytotoxic preparation unit simulation to evaluate the pharmacy staff knowledge.
    Cotteret C; Marry S; Loeuillet R; Videau M; Cisternino S; Schlatter J
    J Oncol Pharm Pract; 2019 Jul; 25(5):1187-1194. PubMed ID: 30626271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parenteral product error detection before and after implementation of intravenous workflow management technology.
    Wright KR; Dekarske B; Clark JS; Chaffee BW
    J Oncol Pharm Pract; 2019 Jan; 25(1):5-15. PubMed ID: 28776479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of robotic antineoplastic preparation on safety, workflow, and costs.
    Seger AC; Churchill WW; Keohane CA; Belisle CD; Wong ST; Sylvester KW; Chesnick MA; Burdick E; Wien MF; Cotugno MC; Bates DW; Rothschild JM
    J Oncol Pract; 2012 Nov; 8(6):344-9, 1 p following 349. PubMed ID: 23598843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.